Literature DB >> 21628401

Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events.

Luca Cecchetti1, Neal D Tolley, Noemi Michetti, Loredana Bury, Andrew S Weyrich, Paolo Gresele.   

Abstract

Megakaryocytes transfer a diverse and functional transcriptome to platelets during the final stages of thrombopoiesis. In platelets, these transcripts reflect the expression of their corresponding proteins and, in some cases, serve as a template for translation. It is not known, however, if megakaryocytes differentially sort mRNAs into platelets. Given their critical role in vascular remodeling and inflammation, we determined whether megakaryocytes selectively dispense transcripts for matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) into platelets. Next-generation sequencing (RNA-Seq) revealed that megakaryocytes express mRNA for 10 of the 24 human MMP family members. mRNA for all of these MMPs are present in platelets with the exception of MMP-2, 14, and 15. Megakaryocytes and platelets also express mRNA for TIMPs 1-3, but not TIMP-4. mRNA expression patterns predicted the presence and, in most cases, the abundance of each corresponding protein. Nonetheless, exceptions were observed: MMP-2 protein is present in platelets but not its transcript. In contrast, quiescent platelets express TIMP-2 mRNA but only traces of TIMP-2 protein. In response to activating signals, however, platelets synthesize significant amounts of TIMP-2 protein. These results demonstrate that megakaryocytes differentially express mRNAs for MMPs and TIMPs and selectively transfer a subset of these into platelets. Among the platelet messages, TIMP-2 serves as a template for signal-dependent translation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628401      PMCID: PMC3158719          DOI: 10.1182/blood-2010-12-324517

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease.

Authors:  Nalini Raghavachari; Xiuli Xu; Amy Harris; Jose Villagra; Carolea Logun; Jennifer Barb; Michael A Solomon; Anthony F Suffredini; Robert L Danner; Gregory Kato; Peter J Munson; Sidney M Morris; Mark T Gladwin
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

2.  Dynamic visualization of thrombopoiesis within bone marrow.

Authors:  Tobias Junt; Harald Schulze; Zhao Chen; Steffen Massberg; Tobias Goerge; Andreas Krueger; Denisa D Wagner; Thomas Graf; Joseph E Italiano; Ramesh A Shivdasani; Ulrich H von Andrian
Journal:  Science       Date:  2007-09-21       Impact factor: 47.728

3.  The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression.

Authors:  Corinna Giorgi; Gene W Yeo; Martha E Stone; Donald B Katz; Christopher Burge; Gina Turrigiano; Melissa J Moore
Journal:  Cell       Date:  2007-07-13       Impact factor: 41.582

Review 4.  Mechanics of proplatelet elaboration.

Authors:  J E Italiano; S Patel-Hett; J H Hartwig
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

Review 5.  Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function.

Authors:  Guy A Zimmerman; Andrew S Weyrich
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03       Impact factor: 8.311

6.  Translation of glycoprotein IIIa in stored blood platelets.

Authors:  Jonathan N Thon; Dana V Devine
Journal:  Transfusion       Date:  2007-08-21       Impact factor: 3.157

Review 7.  Potentiation and priming of platelet activation: a potential target for antiplatelet therapy.

Authors:  Paolo Gresele; Emanuela Falcinelli; Stefania Momi
Journal:  Trends Pharmacol Sci       Date:  2008-06-06       Impact factor: 14.819

8.  Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.

Authors:  Aileen M Healy; Michael D Pickard; Aruna D Pradhan; Yunmei Wang; Zhiping Chen; Kevin Croce; Masashi Sakuma; Can Shi; Alexandre C Zago; Joseph Garasic; Andrew I Damokosh; Tracy L Dowie; Louis Poisson; James Lillie; Peter Libby; Paul M Ridker; Daniel I Simon
Journal:  Circulation       Date:  2006-05-08       Impact factor: 29.690

9.  Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.

Authors:  Emanuela Falcinelli; Silvia Giannini; Enrico Boschetti; Paolo Gresele
Journal:  Br J Haematol       Date:  2007-07       Impact factor: 6.998

10.  Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets.

Authors:  Hansjörg Schwertz; Neal D Tolley; Jason M Foulks; Melvin M Denis; Ben W Risenmay; Michael Buerke; Rachel E Tilley; Matthew T Rondina; Estelle M Harris; Larry W Kraiss; Nigel Mackman; Guy A Zimmerman; Andrew S Weyrich
Journal:  J Exp Med       Date:  2006-10-23       Impact factor: 14.307

View more
  54 in total

1.  Blood platelets contain tumor-derived RNA biomarkers.

Authors:  R Jonas A Nilsson; Leonora Balaj; Esther Hulleman; Sjoerd van Rijn; D Michiel Pegtel; Maudy Walraven; Anders Widmark; Winald R Gerritsen; Henk M Verheul; W Peter Vandertop; David P Noske; Johan Skog; Thomas Würdinger
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

2.  Platelets and platelet-like particles mediate intercellular RNA transfer.

Authors:  Antonina Risitano; Lea M Beaulieu; Olga Vitseva; Jane E Freedman
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

Review 3.  The Platelet Lifeline to Cancer: Challenges and Opportunities.

Authors:  Monika Haemmerle; Rebecca L Stone; David G Menter; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 31.743

4.  Proteasome function is required for platelet production.

Authors:  Dallas S Shi; Matthew C P Smith; Robert A Campbell; Patrick W Zimmerman; Zechariah B Franks; Bjorn F Kraemer; Kellie R Machlus; Jing Ling; Patrick Kamba; Hansjörg Schwertz; Jesse W Rowley; Rodney R Miles; Zhi-Jian Liu; Martha Sola-Visner; Joseph E Italiano; Hilary Christensen; Walter H A Kahr; Dean Y Li; Andrew S Weyrich
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

5.  Slowed decay of mRNAs enhances platelet specific translation.

Authors:  Eric W Mills; Rachel Green; Nicholas T Ingolia
Journal:  Blood       Date:  2017-02-17       Impact factor: 22.113

6.  The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium.

Authors:  Thejaswi Kalagara; Tracy Moutsis; Yi Yang; Karin I Pappelbaum; Anne Farken; Lucia Cladder-Micus; Sabine Vidal-Y-Sy; Axel John; Alexander T Bauer; Bruno M Moerschbacher; Stefan W Schneider; Christian Gorzelanny
Journal:  Blood Adv       Date:  2018-09-25

Review 7.  Platelet mRNA: the meaning behind the message.

Authors:  Jesse W Rowley; Hansjörg Schwertz; Andrew S Weyrich
Journal:  Curr Opin Hematol       Date:  2012-09       Impact factor: 3.284

Review 8.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

Review 9.  MicroRNAs in platelet function and cardiovascular disease.

Authors:  David D McManus; Jane E Freedman
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

Review 10.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.